133 related articles for article (PubMed ID: 18525462)
21. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.
Fury MG; Antonescu CR; Van Zee KJ; Brennan MF; Maki RG
Cancer J; 2005; 11(3):241-7. PubMed ID: 16053668
[TBL] [Abstract][Full Text] [Related]
22. [Preclinical and clinical results in the simultaneous radiochemotherapy of head and neck tumors with Paclitaxel].
Hoffmann W; Heinrich V; Belka C; Budach W; Schmidberger H; Bochtler H; Rodemann HP; Bamberg M
Strahlenther Onkol; 1996 May; 172 Suppl 1():15-20. PubMed ID: 8633268
[No Abstract] [Full Text] [Related]
23. [New treatment of cystic hygromas/lymphangiomas].
Charabi BW; Nielsen LH; Jensen F; Claesson G; Bretlau P
Ugeskr Laeger; 2005 Apr; 167(14):1505-8. PubMed ID: 15887744
[No Abstract] [Full Text] [Related]
24. Cutaneous angiosarcoma clinically presenting as progressive solid facial edema in a 43-year-old male.
Choi WT; Stetsenko GY; Zhang J; Olerud JE; Argenyi ZB; George E
Dermatol Online J; 2013 Nov; 19(11):20409. PubMed ID: 24314784
[TBL] [Abstract][Full Text] [Related]
25. The head-tilt maneuver: a clinical aid in recognizing head and neck angiosarcomas.
Asgari MM; Cockerell CJ; Weitzul S
Arch Dermatol; 2007 Jan; 143(1):75-7. PubMed ID: 17224545
[TBL] [Abstract][Full Text] [Related]
26. The role of paclitaxel in the treatment of head and neck cancer.
Vokes EE; Haraf DJ; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum RR
Semin Oncol; 1995 Oct; 22(5 Suppl 12):8-12. PubMed ID: 7481866
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature.
Funato M; Fukao T; Sasai H; Hori T; Terazawa D; Kanda K; Ozeki M; Mizuta K; Hirose Y; Kaneko H; Kondo N
Head Neck; 2013 Aug; 35(8):E258-61. PubMed ID: 22907922
[TBL] [Abstract][Full Text] [Related]
28. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.
Gambini D; Visintin R; Locatelli E; Bareggi C; Galassi B; Runza L; Blundo C; Sosnovskikh I; Tomirotti M
Tumori; 2015 Apr; 101(2):e60-3. PubMed ID: 25744864
[TBL] [Abstract][Full Text] [Related]
29. Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalp.
Hofmann UB; Wobser M; Kneitz H; Kleine P; Becker JC; Bröcker EB; Ugurel S
Br J Dermatol; 2009 Feb; 160(2):456-8. PubMed ID: 19077074
[No Abstract] [Full Text] [Related]
30. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
[TBL] [Abstract][Full Text] [Related]
31. Partial response of angiosarcoma of the scalp to sorafenib: association with decreased expression of vascular endothelial growth factors and their receptors.
Tamiya H; Kamo R; Kumei A; Yanagihara S; Ishii M; Kobayashi H
Clin Exp Dermatol; 2012 Oct; 37(7):749-52. PubMed ID: 22369131
[TBL] [Abstract][Full Text] [Related]
32. Combined nab-paclitaxel and irradiation for large cutaneous angiosarcoma of the face and scalp with pulmonary metastases.
André F; Frischhut N; Walder A; Skvortsov S; Schmuth M; Nguyen VA
J Dtsch Dermatol Ges; 2020 Jul; 18(7):754-757. PubMed ID: 32469459
[No Abstract] [Full Text] [Related]
33. Familial cardiac angiosarcoma.
Keeling IM; Ploner F; Rigler B
Ann Thorac Surg; 2006 Oct; 82(4):1576. PubMed ID: 16996998
[No Abstract] [Full Text] [Related]
34. A congenital neck mass.
Toranzo JM; Guerrero F; Dibildox J; Gonzalez G; Sedano HO
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):363-4. PubMed ID: 8899771
[No Abstract] [Full Text] [Related]
35. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
[TBL] [Abstract][Full Text] [Related]
36. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin.
Mathew P; Vakar-Lopez F; Troncoso P
Lancet Oncol; 2006 Jan; 7(1):92-3. PubMed ID: 16389189
[No Abstract] [Full Text] [Related]
37. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
38. Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report.
Tomasello L; Gardin G; Boccardo F
Anticancer Res; 2006; 26(6C):4775-7. PubMed ID: 17214340
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle albumin-bound paclitaxel can be useful agent to advanced primary mucinous carcinoma of the skin.
Homma E; Hata H; Tsujiwaki M; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2271-3. PubMed ID: 24910079
[No Abstract] [Full Text] [Related]
40. Spontaneous regression of chemotherapy-resistant metastases from a scalp angiosarcoma.
Suzuki M; Matsuzuka T; Ikeda M; Nakaegawa Y; Kobayashi T; Kawase T; Kobari T; Murono S
Fukushima J Med Sci; 2017 Aug; 63(2):106-111. PubMed ID: 28680008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
